Retrospective Analysis of Prognostic Factors Associated With Response and Overall Survival by Baseline Marrow Blast Percentage in Patients With Myelodysplastic Syndromes Treated With Decitabine

Decitabine improves overall survival in myelodysplastic syndromes (MDS). This retrospective analysis of 2 decitabine studies (N=183) compared patients with baseline marrow blasts ≥20% (RAEB-t group, acute myeloid leukemia [AML] by WHO criteria) and <20% (MDS group). There was no significant diffe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jabbour, Elias, Kantarjian, Hagop, O’Brien, Susan, Kadia, Tapan, Malik, Asifa, Welch, Mary-Alma, Teng, Angela, Cortes, Jorge, Ravandi, Farhad, Garcia-Manero, Guillermo
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120256/
https://ncbi.nlm.nih.gov/pubmed/23790798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2013.05.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados